Novel blood biomarkers of pancreatic cancer-associated diabetes mellitus identified by peripheral blood-based gene expression profiles. (Q54422958)

29 May 2018

title

Novel blood biomarkers of pancreatic cancer-associated diabetes mellitus identified by peripheral blood-based gene expression profiles. (English)

1 reference

29 May 2018

0 references

Hai Huang

1

1 reference

29 May 2018

Xin Dong

2

1 reference

29 May 2018

Mu Xing Kang

3

1 reference

29 May 2018

Bin Xu

4

1 reference

29 May 2018

Ying Chen

5

1 reference

29 May 2018

Bo Zhang

6

1 reference

29 May 2018

Jian Chen

7

1 reference

29 May 2018

Qiu Ping Xie

8

1 reference

29 May 2018

Yu Lian Wu

9

1 reference

29 May 2018

language of work or name

English

0 references

publication date

22 June 2010

1 reference

29 May 2018

The American Journal of Gastroenterology

published in

1 reference

29 May 2018

volume

105

1 reference

29 May 2018

page(s)

1661-1669

1 reference

29 May 2018

issue

7

1 reference

29 May 2018

Pancreatic cancer: basic and clinical aspects

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.32

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.32

Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.32

Small carcinoma of the pancreas is curable: new computed tomography finding, pathological study and postoperative results from a single institute.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.32

Reappraisal of the clinical significance of tumor size in patients with pancreatic ductal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.32

Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.32

New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.32

Pantetheinase activity of membrane-bound Vanin-1: lack of free cysteamine in tissues of Vanin-1 deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.32

Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.32

Prognostic and therapeutic significance of carbohydrate antigen 19-9 as tumor marker in patients with pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.32

Advances in the early detection, diagnosis, and staging of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.32

Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.32

Mimicks of pancreatic malignancy in patients with chronic pancreatitis: correlation of computed tomography imaging features with histopathologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.32

Assessment of EUS for diagnosing, staging, and determining resectability of pancreatic cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.32

Endoscopic ultrasonographic diagnosis of pancreatic cancer complicating chronic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.32

Discovery of novel tumor markers of pancreatic cancer using global gene expression technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.32

New markers of pancreatic cancer identified through differential gene expression analyses: claudin 18 and annexin A8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.32

Expression of HOXB2, a retinoic acid signaling target in pancreatic cancer and pancreatic intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.32

Clinical proteomics: Written in blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.32

Novel blood-based, five-gene biomarker set for the detection of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.32

Novel blood biomarkers of human urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.32

Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: a retrospective review of CT scans and fasting glucose values prior to diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.32

Is pantetheinase the actual identity of mouse and human vanin-1 proteins?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.32

Vanin-1-/- mice exhibit a glutathione-mediated tissue resistance to oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.32

Mouse vanin-1 is cytoprotective for islet beta cells and regulates the development of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.32

Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.32

Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.32

Establishing the added benefit of measuring MMP9 in FOB positive patients as a part of the Wolverhampton colorectal cancer screening programme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.32

21 January 2018

Identifiers

DOI

10.1038/AJG.2010.32

1 reference

29 May 2018

PubMed ID

20571492

1 reference

29 May 2018